Topic · page 33 of 40

Rheumatoid arthritis

Early and established rheumatoid arthritis in adults: diagnosis and prediction (clinically suspect arthralgia, people at risk), treat-to-target, conventional, biologic and targeted synthetic drugs, tapering and withdrawal, glucocorticoids, extra-articular disease and rheumatoid arthritis–associated interstitial lung disease

Briefs 1,281–1,320 of 1,564 placed here, newest publication first

Briefs in Rheumatoid arthritis

Newest publication first

RMD Open19 May 2023
New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis
Mechanistic study
Arthritis Res Ther19 May 2023
Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity – a randomized controlled trial
Randomized controlled trial
N Engl J Med18 May 2023
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
Randomized controlled trial
RMD Open16 May 2023
Self-evidence-based digital care programme improves health-related quality of life in adults with a variety of autoimmune diseases and long COVID: a retrospective study
Cohort study
Rheumatology (Oxford)15 May 2023
Adherence to dietary guidelines, and the risk of developing rheumatoid arthritis: results from a nested case-control study
Case-control study
J Rheumatol15 May 2023
Avoiding Blunders When Analyzing Correlated Data, Clustered Data, or Repeated Measures
Secondary analysis
Rheumatology (Oxford)15 May 2023
Fibroblast growth factor receptor 1 as a potential marker of terminal effector peripheral T helper cells in rheumatoid arthritis patients
Mechanistic study
Clin Exp Rheumatol14 May 2023
Biologics initiation in moderate versus severe rheumatoid arthritis: real-world experience from a Canadian registry
Cohort study
Arthritis Rheumatol9 May 2023
Identification of Cell‐Specific Differential DNA Methylation Associated With Methotrexate Treatment Response in Rheumatoid Arthritis
Mechanistic study
RMD Open8 May 2023
‘It surprised me a lot that there is a link’: a qualitative study of the acceptability of periodontal treatment for individuals at risk of rheumatoid arthritis
Research article
Semin Arthritis Rheum5 May 2023
Temporomandibular disorders in immune-mediated rheumatic diseases of the adult: A systematic review
Meta-analysis
Semin Arthritis Rheum5 May 2023
Time Trends in Glucocorticoid Use in Rheumatoid Arthritis During the Biologics Era: 1999-2018
Cohort study
Semin Arthritis Rheum5 May 2023
Risk of venous thromboembolism in Korean patients with rheumatoid arthritis treated with Janus kinase inhibitors: A nationwide population-based study
Cohort study
Clin Exp Rheumatol4 May 2023
Causal relationship between gut microbiota and rheumatoid arthritis: a two-sample Mendelian randomisation study
Research article
Arthritis Res Ther3 May 2023
Multi-omics profiling reveals potential alterations in rheumatoid arthritis with different disease activity levels
Mechanistic study
Rheumatology (Oxford)2 May 2023
Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry
Cohort study
J Rheumatol1 May 2023
Integrating PROMIS Measures in a Treat-to-Target Approach to Standardize Patient-Centered Treatment of Rheumatoid Arthritis
Cohort study
JAMA Netw Open1 May 2023
Therapeutic Equivalence of Biosimilar and Reference Biologic Drugs in Rheumatoid Arthritis: A Systematic Review and Meta-analysis
Meta-analysis
Lancet RheumatolMay 2023
Evaluation of BMS-986142, a reversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2, randomised, double-blind, dose-ranging, placebo-controlled, adaptive design study
Randomized controlled trial
RMD Open28 Apr 2023
What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis
Meta-analysis
Arthritis Res Ther27 Apr 2023
Comparisons of treatment satisfaction and health-related quality of life in patients with rheumatoid arthritis treated with tofacitinib and adalimumab
Cross-sectional study
Arthritis Rheumatol27 Apr 2023
Autoantibodies to Disease‐Related Proteins in Joints as Novel Biomarkers for the Diagnosis of Rheumatoid Arthritis
Diagnostic or prognostic study
Clin Exp Rheumatol26 Apr 2023
Prevalence of coeliac disease in patients with rheumatoid arthritis and juvenile idiopathic arthritis: a systematic review and meta-analysis
Meta-analysis
Clin Exp Rheumatol26 Apr 2023
Real-world effectiveness of golimumab in the treatment of patients with active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who failed initial TNF-α inhibitor therapy: a pooled analysis of European prospective observational studies (the GO-BEYOND program)
Meta-analysis
RMD Open25 Apr 2023
Repair of joint damage in patients with rheumatoid arthritis does not relate to previous suppression of inflammation: a subanalysis after 8 years treat-to-target in the BeSt-trial
Secondary analysis
RMD Open25 Apr 2023
Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study
Randomized controlled trial
Arthritis Res Ther22 Apr 2023
The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study
Secondary analysis
Arthritis Res Ther22 Apr 2023
Glutathione peroxidase 3 is a novel clinical diagnostic biomarker and potential therapeutic target for neutrophils in rheumatoid arthritis
Mechanistic study
Scand J Rheumatol21 Apr 2023
Unsupervised clustering to differentiate rheumatoid arthritis patients based on proteomic signatures
Cohort study
Scand J Rheumatol17 Apr 2023
Clinical and preclinical pulmonary disease in newly diagnosed rheumatoid arthritis: a two-year follow-up study
Cohort study
Arthritis Care Res (Hoboken)17 Apr 2023
Updating and Validating the Rheumatic Disease Comorbidity Index to Incorporate ICD‐10‐CM Diagnostic Codes
Diagnostic or prognostic study
J Rheumatol15 Apr 2023
Factors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid Arthritis
Secondary analysis
Rheumatology (Oxford)13 Apr 2023
Cancer risk in patients with rheumatoid arthritis treated with janus kinase inhibitors: a nationwide Danish register-based cohort study
Cohort study
Arthritis Res Ther13 Apr 2023
Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα NANOBODY® compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials
Secondary analysis
Arthritis Rheumatol13 Apr 2023
Reduction of Proinflammatory Effector Functions Through Remodeling of Fatty Acid Metabolism in CD8 + T Cells From Rheumatoid Arthritis Patients
Mechanistic study
Arthritis Rheumatol12 Apr 2023
Disease Activity and Health‐Related Quality of Life Among Patients With Rheumatoid Arthritis With Different Alcohol Consumption Habits
Cohort study
Semin Arthritis Rheum10 Apr 2023
Enhancing the identification of rheumatoid arthritis-associated interstitial lung disease through text mining of chest computerized tomography reports
Diagnostic or prognostic study
Clin Exp Rheumatol6 Apr 2023
A comparative study on the clinical and magnetic resonance imaging features between seronegative and seropositive rheumatoid arthritis
Cohort study
Ann Rheum Dis5 Apr 2023
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis
Cohort study
Rheumatology (Oxford)4 Apr 2023
Risk of severe infections after the introduction of biologic DMARDs in people with newly diagnosed rheumatoid arthritis: a population-based interrupted time-series analysis
Cohort study

All 1,564 Briefs in ExploreShowing Briefs 1,281–1,320 of 1,564, newest first